Logo image of FEMY

FEMASYS INC (FEMY) Stock Price, Quote, News and Overview

NASDAQ:FEMY - Nasdaq - US31447E1055 - Common Stock - Currency: USD

1.16  -0.01 (-0.85%)

After market: 1.24 +0.08 (+6.9%)

FEMY Quote, Performance and Key Statistics

FEMASYS INC

NASDAQ:FEMY (4/30/2025, 9:35:39 AM)

After market: 1.24 +0.08 (+6.9%)

1.16

-0.01 (-0.85%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High1.8
52 Week Low0.86
Market Cap31.49M
Shares27.15M
Float23.83M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08
IPO06-18 2021-06-18


FEMY short term performance overview.The bars show the price performance of FEMY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6

FEMY long term performance overview.The bars show the price performance of FEMY in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of FEMY is 1.16 USD. In the past month the price decreased by -6.4%. In the past year, price decreased by -9.3%.

FEMASYS INC / FEMY Daily stock chart

FEMY Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.15 225.11B
ISRG INTUITIVE SURGICAL INC 66.25 181.33B
BSX BOSTON SCIENTIFIC CORP 37.75 150.75B
SYK STRYKER CORP 30.5 141.91B
MDT MEDTRONIC PLC 15.83 108.41B
BDX BECTON DICKINSON AND CO 14.83 59.24B
EW EDWARDS LIFESCIENCES CORP 29.27 44.75B
IDXX IDEXX LABORATORIES INC 38.28 34.90B
RMD RESMED INC 25.74 34.32B
GEHC GE HEALTHCARE TECHNOLOGY 15.89 32.66B
DXCM DEXCOM INC 42.61 27.57B
PHG KONINKLIJKE PHILIPS NVR- NY 15.88 23.58B

About FEMY

Company Profile

FEMY logo image Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company is headquartered in Suwanee, Georgia and currently employs 69 full-time employees. The company went IPO on 2021-06-18. The firm is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The company also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Company Info

FEMASYS INC

3950 Johns Creek Court, Suite 100

Suwanee GEORGIA US

CEO: Kathy Lee-Sepsick

Employees: 33

Company Website: https://www.femasys.com/

Investor Relations: https://ir.femasys.com/

Phone: 17705003910

FEMASYS INC / FEMY FAQ

What is the stock price of FEMASYS INC today?

The current stock price of FEMY is 1.16 USD. The price decreased by -0.85% in the last trading session.


What is the ticker symbol for FEMASYS INC stock?

The exchange symbol of FEMASYS INC is FEMY and it is listed on the Nasdaq exchange.


On which exchange is FEMY stock listed?

FEMY stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for FEMASYS INC stock?

10 analysts have analysed FEMY and the average price target is 8.84 USD. This implies a price increase of 662.07% is expected in the next year compared to the current price of 1.16. Check the FEMASYS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FEMASYS INC worth?

FEMASYS INC (FEMY) has a market capitalization of 31.49M USD. This makes FEMY a Nano Cap stock.


How many employees does FEMASYS INC have?

FEMASYS INC (FEMY) currently has 33 employees.


What are the support and resistance levels for FEMASYS INC (FEMY) stock?

FEMASYS INC (FEMY) has a support level at 1.13 and a resistance level at 1.17. Check the full technical report for a detailed analysis of FEMY support and resistance levels.


Is FEMASYS INC (FEMY) expected to grow?

The Revenue of FEMASYS INC (FEMY) is expected to grow by 222.54% in the next year. Check the estimates tab for more information on the FEMY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FEMASYS INC (FEMY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FEMASYS INC (FEMY) stock pay dividends?

FEMY does not pay a dividend.


When does FEMASYS INC (FEMY) report earnings?

FEMASYS INC (FEMY) will report earnings on 2025-05-08.


What is the Price/Earnings (PE) ratio of FEMASYS INC (FEMY)?

FEMASYS INC (FEMY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.85).


What is the Short Interest ratio of FEMASYS INC (FEMY) stock?

The outstanding short interest for FEMASYS INC (FEMY) is 3.57% of its float. Check the ownership tab for more information on the FEMY short interest.


FEMY Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to FEMY. When comparing the yearly performance of all stocks, FEMY turns out to be only a medium performer in the overall market: it outperformed 41.86% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FEMY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to FEMY. Both the profitability and financial health of FEMY have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FEMY Financial Highlights

Over the last trailing twelve months FEMY reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS increased by 7.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -151.2%
ROE -816.56%
Debt/Equity 2.35
Chartmill High Growth Momentum
EPS Q2Q%-21.05%
Sales Q2Q%173.24%
EPS 1Y (TTM)7.61%
Revenue 1Y (TTM)52.61%

FEMY Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to FEMY. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 41.2% and a revenue growth 222.54% for FEMY


Ownership
Inst Owners10.22%
Ins Owners7.4%
Short Float %3.57%
Short Ratio1.77
Analysts
Analysts82
Price Target8.84 (662.07%)
EPS Next Y41.2%
Revenue Next Year222.54%